ANDA 75618, held by Hikma International Pharmaceuticals. Acetaminophen; Butalbital; Caffeine; Codeine Phosphate.
As of Nov 18, 2026, ANDA 75618 (Butalbital, Acetaminophen, Caffeine And Codeine Phosphate), held by Hikma International Pharmaceuticals, was first approved by FDA on Mar 23, 2001, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 23, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butalbital, Acetaminophen, Caffeine And Codeine Phosphate325MG;50MG;40MG;30MG · capsule;oral | Acetaminophen; Butalbital; Caffeine; Codeine Phosphate | Discontinued |
| Sep 18, 2018 | Supplement 27REMS | Approved | None posted |
| Jun 1, 2017 | Supplement 25Labeling · Standard review | Approved | None posted |
| Jun 1, 2015 | Supplement 23Labeling · Standard review | Approved | None posted |
| Aug 1, 2014 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jul 8, 2011 | Supplement 19Labeling | Approved | None posted |
| May 8, 2009 | Supplement 17Labeling | Approved | None posted |
| Jan 26, 2008 | Supplement 3Manufacturing | Approved | None posted |
| Nov 7, 2007 | Supplement 15Labeling | Approved | None posted |
| Dec 29, 2003 | Supplement 12Labeling | Approved | None posted |
| Jan 25, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Mar 23, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters